Search anything
Ctrl+K
Welcome to Multibagg AI
Log in to access personalized features
Welcome to Multibagg AI
Log in to access personalized features
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Motilal Oswal reiterates a 'Buy' rating on Bikaji Foods, setting a target price of ₹900, citing strong growth prospects and strategic expansion into new product categories.
Indian benchmark indices Sensex and Nifty50 experienced a significant crash, driven by escalating geopolitical tensions in West Asia and Brent crude oil prices surpassing $100 per barrel.
Aster DM Healthcare and Quality Care India have received NCLT approval to hold shareholder meetings, moving closer to creating India's third-largest hospital chain by Q1 FY2026-27.
India invokes the Essential Commodities Act to prioritize domestic LPG supply amid a severe commercial cylinder shortage affecting restaurants and transport across major cities.
Key stocks like Wipro, Adani Enterprises, KEC International, and Ashok Leyland are in focus today amid market volatility driven by geopolitical tensions and rising crude oil prices.
Dixon Technologies reported a 68% jump in Q3 profit, but the surge was driven by a one-time gain, masking a slowdown in its core smartphone business.
Despite a recent stock underperformance and a weaker-than-expected Q3, Motilal Oswal maintains a 'Buy' rating on Maruti Suzuki, citing strong product launches and export growth.
Motilal Oswal reiterates a 'Buy' rating on Maruti Suzuki, forecasting significant upside driven by market share recovery, new launches, and strong export growth.
Jefferies reiterates its 'Buy' rating on Coal India, raising the price target to ₹485, citing expected recovery in power demand and attractive valuations.
Geopolitical tensions in the Middle East have pushed crude oil prices near $100 per barrel, boosting shares of upstream producers like ONGC and Oil India while pressuring downstream oil marketing companies.
5paisa Capital has finalized the terms for its rights issue, aiming to raise ₹468.8 crore by offering shares at ₹300 each with a 1:2 entitlement ratio.
5paisa Capital has finalized the terms for its ₹468.8 crore rights issue, offering shares at ₹300 each with a record date of March 17, 2026.
Skyline Ventures India Limited has completely restructured its board, removing three directors and appointing three new ones following an EGM driven by shareholder concerns.
The International Energy Agency will release a historic 400 million barrels from emergency reserves to stabilize global markets disrupted by the conflict in Iran.
Aster DM Healthcare secures near-unanimous shareholder and creditor approval for its merger with Quality Care India, paving the way for one of India's largest hospital networks.
Ahmedabad-based GSP Crop Science is set to launch its IPO on March 16, aiming to raise ₹240 crore through a fresh issue amid volatile market conditions.
